NeuroMetrix's Quell neuromodulation device wins FDA de novo nod to treat fibromyalgia

NeuroMetrix announced today that it received FDA de novo authorization for its Quell neuromodulation device, indicated to treat fibromyalgia.

Related Keywords

Shain Gozani , , Patient Global Impression , Fibromyalgia Impact Questionnaire ,